MYC(v-myc avian myelocytomatosis viral oncogene homolog)
基因简称(symbol)
基因种类(locus group)
同源简称(alias symbol)
基因家族代码(gene_family_id)
omim代码
entrez码
vega基因码
ensembl基因码
基因家族(gene family)
refseq数据库代号
更多...
基因种类(locus_type)
基因名称状态(status)
location_sortable
同源基因名称(alias name)
基因名称批准使用时间(date_approved_reserved)
基因简称更名时间(date_symbol_changed)
基因名称更名时间(date_name_changed)
更新时间(date_modified)
ucsc码
ena
ccds数据码
uniprot数据码
pubmed代码
mgd码
rgd码
生命科学数据库(lsdb)
更新时间(date modified)
cosmic
mirbase
基因曾用简称(prev symbol)
基因曾用名称(prev name)
homeodb
cosmic
snornabase
bioparadigms slc
orphanet
假基因信息(pseudogeneorg)
horde id
merops
imgt
iuphar
kznf基因类别
mamit-trnadb
cd
LncRNA数据库
酶代码
中间纤维数据库
收起
The protein encoded by this gene is a multifunctional, nuclear phosphoprotein that plays a role in cell cycle progression, apoptosis and cellular transformation. It functions as a transcription factor that regulates transcription of specific target genes. Mutations, overexpression, rearrangement and translocation of this gene have been associated with a variety of hematopoietic tumors, leukemias and lymphomas, including Burkitt lymphoma. There is evidence to show that alternative translation initiations from an upstream, in-frame non-AUG (CUG) and a downstream AUG start site result in the production of two isoforms with distinct N-termini. The synthesis of non-AUG initiated protein is suppressed in Burkitt's lymphomas, suggesting its importance in the normal function of this gene. [provided by RefSeq, Jul 2008]
[中文简述(自动翻译):] 由该基因编码的蛋白质是一种多功能的，核磷蛋白即在细胞周期进程，细胞凋亡和细胞转化的作用。它起到一种调节的特定靶基因转录的转录因子。突变，过度表达，重排和该基因的易位已与多种造血肿瘤，白血病和淋巴瘤，包括伯基特淋巴瘤有关。有证据表明，来自上游，在帧非-AUG（CUG）和下游AUG起始位点的结果在生产两种异构体具有不同的N-末端的替代翻译灌顶。非AUG启动蛋白的合成被抑制在伯基特淋巴瘤，表明该基因的正常功能的重要性。 [由RefSeq的，2008年7月提供]
MYC基因的碱基突变：
显示全部snp
rs3808379
rs3824120
rs4645939
rs4645940
rs4645941
rs4645942
rs4645943
rs4645944
rs4645945
rs17187428
rs28461617
rs35532759
rs71300261
rs117134852
rs117576103
rs117748025
rs141631033
rs146032527
rs147436834
rs148051381
rs180769192
rs181665190
rs185630499
rs186019633
rs199883308
rs200042029
rs201975172
rs397843665
rs529583325
rs530130631
rs531737369
rs531866982
rs535867931
rs535903672
rs538014647
rs540038010
rs542231563
rs546283688
rs547778174
rs552488552
rs552828696
rs558420167
rs558755639
rs560576306
rs562023036
rs564482328
rs566465558
rs570523723
rs572448525
rs572966058
rs577059902
rs14607
rs2070582
rs2070583
rs2071346
rs3891248
rs4645946
rs4645947
rs4645948
rs4645949
rs4645950
rs4645951
rs4645952
rs4645953
rs4645954
rs4645955
rs4645956
rs4645957
rs4645958
rs4645959
rs4645960
rs4645961
rs4645962
rs4645963
rs4645964
rs4645965
rs4645966
rs4645967
rs4645968
rs4645969
rs4645970
rs4645971
rs10110283
rs10706841
rs35524866
rs61752959
rs73707291
rs73707292
rs73707293
rs73707294
rs74386365
rs75369521
rs79306211
rs112602073
rs113152741
rs113705007
rs114570780
rs117672626
rs117856857
rs137906262
rs139112155
rs139294902
rs139697494
rs140142417
rs140182565
rs141008372
rs141095253
rs141349735
rs141503199
rs143241117
rs143376340
rs143417056
rs143501729
rs143550928
rs143766674
rs143895359
rs145561065
rs146504683
rs146505192
rs146523831
rs146971340
rs147506213
rs148188362
rs148228388
rs148863193
rs148915481
rs149534345
rs149689040
rs149992096
rs150308400
rs150629172
rs151033540
rs181048497
rs181649764
rs182162908
rs183539672
rs183850214
rs184271012
rs185260785
rs185650723
rs185892131
rs186425113
rs186663828
rs186781003
rs188286537
rs188937617
rs190092855
rs190322311
rs190498866
rs191466112
rs199561469
rs199809179
rs200431478
rs200447778
rs200570465
rs201238897
rs201337668
rs368747661
rs369195017
rs369952293
rs369978120
rs370767192
rs372115981
rs372210680
rs373030192
rs373577293
rs373711147
rs374225230
rs374701735
rs374718932
rs374754442
rs375133960
rs375402667
rs375812644
rs376985810
rs398009849
rs527300420
rs529015137
rs529123559
rs530292752
rs530668928
rs530751752
rs531476381
rs532694924
rs533002445
rs533212135
rs533487784
rs534556090
rs534850950
rs535140789
rs535709985
rs535921169
rs535929859
rs536396530
rs536910236
rs536993570
rs537112652
rs538226450
rs538314263
rs539390724
rs539392826
rs541331885
rs541595179
rs541914583
rs541930040
rs542316783
rs542384179
rs542485904
rs543426727
rs543513193
rs543515847
rs543595570
rs543718581
rs544605712
rs544642878
rs544792311
rs545330879
rs545977969
rs547562331
rs547638803
rs548284320
rs548552831
rs548795602
rs549914515
rs550000037
rs550160158
rs550161040
rs551193783
rs551911756
rs552525496
rs552647364
rs552851405
rs553330039
rs553486652
rs554049915
rs554217507
rs554983668
rs555463064
rs555471600
rs556426105
rs556660048
rs556698803
rs557901268
rs558084126
rs558826267
rs559285282
rs559856816
rs560444505
rs561304088
rs562953156
rs563223283
rs564425416
rs565091426
rs565094097
rs565849816
rs565949521
rs566471603
rs567043428
rs567410724
rs568267700
rs568518631
rs569687120
rs569723870
rs571635549
rs572416137
rs573053336
rs573678296
rs573822249
rs574456265
rs574790380
rs575113259
rs576036035
rs576124632
rs576158247
rs576408843
rs577698378
rs578118914
rs578195374
rs745436215
rs745545434
rs745993896
rs746070555
rs746333391
rs746409847
rs746611175
rs746633360
rs746692226
rs746958042
rs747126564
rs747141352
rs747518067
rs747913772
rs748003319
rs748302238
rs748361858
rs748874520
rs748962740
rs749498067
rs749722454
rs749753251
rs749985481
rs750323566
rs750374321
rs750561207
rs750562100
rs750651389
rs750664148
rs750863627
rs751130055
rs751452834
rs751465079
rs751822114
rs752013519
rs752022129
rs752297148
rs752344761
rs752586995
rs752926420
rs753094370
rs753250129
rs753502487
rs753630724
rs753723304
rs753759396
rs753815552
rs753906871
rs753966985
rs754298537
rs754661463
rs754669125
rs754742138
rs754835412
rs755221038
rs755283006
rs755460825
rs755545316
rs755827927
rs756035058
rs756048733
rs756091827
rs756611896
rs756666851
rs756770497
rs756894698
rs757183481
rs757596863
rs757865894
rs758197763
rs758263761
rs758629773
rs758677772
rs758679560
rs758986453
rs759541908
rs759774541
rs759881591
rs759911200
rs759986640
rs760033932
rs760580726
rs760650253
rs760686595
rs760785153
rs761021550
rs761049734
rs761108336
rs761254886
rs761433935
rs761912973
rs761932135
rs762139580
rs762543262
rs762780579
rs762965100
rs763019405
rs763627051
rs763722596
rs763953840
rs764006760
rs764099214
rs764188937
rs764346243
rs764805246
rs765003654
rs765092337
rs765535915
rs765884995
rs765924453
rs766292378
rs766583593
rs766646127
rs766666917
rs766983499
rs766987302
rs767039286
rs767216614
rs767360326
rs767477446
rs767700277
rs768286545
rs768305838
rs768701719
rs768812689
rs769010031
rs769148296
rs769538164
rs769788275
rs770061106
rs770159089
rs770253839
rs770464239
rs770534113
rs770609785
rs770660324
rs770665301
rs770713291
rs770904938
rs771168413
rs771277797
rs771286365
rs771557035
rs771723282
rs772094171
rs772229477
rs772252363
rs772278526
rs772459508
rs772650309
rs772761233
rs772772048
rs772792914
rs772869147
rs773098170
rs773453291
rs773473361
rs773571686
rs773704447
rs773796768
rs774015583
rs774246867
rs774254150
rs775427980
rs775522201
rs775690959
rs775727765
rs775761084
rs775876406
rs775909833
rs776077629
rs776187699
rs776242757
rs776244909
rs776379651
rs776438693
rs776898772
rs777120045
rs777141161
rs777230092
rs777695894
rs777974417
rs777976423
rs777980347
rs778030574
rs778234438
rs778262855
rs778595707
rs779120200
rs779123478
rs779363727
rs779459976
rs779702122
rs779748283
rs779751378
rs779878619
rs780034860
rs780202654
rs780361249
rs780470549
rs780551705
rs781041285
rs781165176
rs781313941
rs781494801
rs869264405
正向引物序列
正向引物Tm值
反向引物序列
反向引物Tm值
rank
GATTCTCTGCTCTCCTCGA
58
TTGTTCCTCCTCAGAGTCG
59
GGATTCTCTGCTCTCCTCG
59
TTGTTCCTCCTCAGAGTCG
59
GGATTCTCTGCTCTCCTCG
59
TTGTTCCTCCTCAGAGTCG
59
ATTCTCTGCTCTCCTCGAC
59
TCTTGTTCCTCCAGAGTCG
59
GATTCTCTGCTCTCCTCGA
58
TTGTTCCTCCTCAGAGTCG
59
GATTCTCTGCTCTCCTCGA
58
TTGTTCCTCCTCAGAGTCG
59
ATTCTCTGCTCTCCTCGAC
59
TTGTTCCTCCTCAGAGTCG
59
GATTCTCTGCTCTCCTCGA
58
TTGTTCCTCCTCAGAGTCG
59
TCTGAAAGGCTCTCCTTGC
60
TGGTGAAGCTAACGTTGAG
58
GGATTCTCTGCTCTCCTCG
59
TTGTTCCTCCTCAGAGTCG
59
基因本体信息
MYC基因（以及对应的蛋白质）的细胞分布位置：
- 溶酶体
- 内涵体
- 细胞核
- 细胞质
- 液泡
- 细胞膜
- 细胞外基质
- 内质网
- 线粒体
- 高尔基体
- 细胞骨架
MYC基因的本体（GO）信息：
GO库代码
对应的蛋白质
来源代码
GO:0003700
A0A087WUS5(UniProtKB)
IEA
GO:0005634
A0A087WUS5(UniProtKB)
IEA
GO:0005819
A0A087WUS5(UniProtKB)
IEA
GO:0006355
A0A087WUS5(UniProtKB)
IEA
GO:0046983
A0A087WUS5(UniProtKB)
IEA
GO:0003700
A0A0B4J1R1(UniProtKB)
IEA
GO:0005634
A0A0B4J1R1(UniProtKB)
IEA
GO:0006355
A0A0B4J1R1(UniProtKB)
IEA
GO:0003700
H0YBG3(UniProtKB)
IEA
GO:0005634
H0YBG3(UniProtKB)
IEA
GO:0006355
H0YBG3(UniProtKB)
IEA
GO:0003700
H0YBT0(UniProtKB)
IEA
GO:0005654
H0YBT0(UniProtKB)
IDA
GO:0006355
H0YBT0(UniProtKB)
IEA
GO:0046983
H0YBT0(UniProtKB)
IEA
GO:0000122
P01106(UniProtKB)
IDA
GO:0000165
P01106(UniProtKB)
IMP
GO:0000978
P01106(UniProtKB)
IDA
GO:0001077
P01106(UniProtKB)
IDA
GO:0001658
P01106(UniProtKB)
ISS
GO:0002053
P01106(UniProtKB)
ISS
GO:0003677
P01106(UniProtKB)
ISS
GO:0003677
P01106(UniProtKB)
TAS
GO:0003700
P01106(UniProtKB)
IDA
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005515
P01106(UniProtKB)
IPI
GO:0005634
P01106(UniProtKB)
IDA
GO:0005634
P01106(UniProtKB)
IDA
GO:0005634
P01106(UniProtKB)
IDA
GO:0005654
P01106(UniProtKB)
IDA
GO:0005654
P01106(UniProtKB)
IDA
GO:0005654
P01106(UniProtKB)
TAS
GO:0005654
P01106(UniProtKB)
TAS
GO:0005654
P01106(UniProtKB)
TAS
GO:0005654
P01106(UniProtKB)
TAS
GO:0005654
P01106(UniProtKB)
TAS
GO:0005730
P01106(UniProtKB)
IDA
GO:0005829
P01106(UniProtKB)
TAS
GO:0006112
P01106(UniProtKB)
NAS
GO:0006338
P01106(UniProtKB)
IDA
GO:0006366
P01106(UniProtKB)
IEA
GO:0006879
P01106(UniProtKB)
IDA
GO:0006974
P01106(UniProtKB)
IDA
GO:0007050
P01106(UniProtKB)
IDA
GO:0007219
P01106(UniProtKB)
TAS
GO:0008134
P01106(UniProtKB)
IPI
GO:0008284
P01106(UniProtKB)
IDA
GO:0010332
P01106(UniProtKB)
IDA
GO:0010468
P01106(UniProtKB)
IDA
GO:0015671
P01106(UniProtKB)
NAS
GO:0032204
P01106(UniProtKB)
IMP
GO:0032403
P01106(UniProtKB)
IDA
GO:0032873
P01106(UniProtKB)
ISS
GO:0034644
P01106(UniProtKB)
IEP
GO:0035690
P01106(UniProtKB)
IDA
GO:0035690
P01106(UniProtKB)
IDA
GO:0042493
P01106(UniProtKB)
IEP
GO:0043066
P01106(UniProtKB)
ISS
GO:0043234
P01106(UniProtKB)
IDA
GO:0043280
P01106(UniProtKB)
IDA
GO:0044346
P01106(UniProtKB)
TAS
GO:0045656
P01106(UniProtKB)
IMP
GO:0045893
P01106(UniProtKB)
IDA
GO:0045893
P01106(UniProtKB)
IDA
GO:0045893
P01106(UniProtKB)
IDA
GO:0045944
P01106(UniProtKB)
IDA
GO:0045944
P01106(UniProtKB)
IMP
GO:0045944
P01106(UniProtKB)
TAS
GO:0046983
P01106(UniProtKB)
IEA
GO:0048146
P01106(UniProtKB)
IMP
GO:0048146
P01106(UniProtKB)
IDA
GO:0048146
P01106(UniProtKB)
IDA
GO:0048147
P01106(UniProtKB)
IDA
GO:0050679
P01106(UniProtKB)
IDA
GO:0051276
P01106(UniProtKB)
IDA
GO:0051782
P01106(UniProtKB)
IDA
GO:0060070
P01106(UniProtKB)
IDA
GO:0070491
P01106(UniProtKB)
IPI
GO:0070848
P01106(UniProtKB)
TAS
GO:0070888
P01106(UniProtKB)
IDA
GO:0090096
P01106(UniProtKB)
ISS
GO:1904837
P01106(UniProtKB)
TAS
GO:2000573
P01106(UniProtKB)
IMP
GO:2001022
P01106(UniProtKB)
IDA
| 疾病名称 | 关系值 | NofPmids | NofSnps | 来源 |
| Burkitt Lymphoma | 0.495996478 | 134 | 4 | BeFree_CLINVAR_CTD_human_LHGDN_MGD_ORPHANET |
| Liver carcinoma | 0.305750759 | 56 | 0 | BeFree_CTD_human_GAD_LHGDN_MGD_RGD |
| Colonic Neoplasms | 0.203538676 | 9 | 0 | BeFree_CTD_human_LHGDN_RGD |
| Liver Neoplasms, Experimental | 0.2 | 4 | 0 | CTD_human_RGD |
| Medulloblastoma | 0.139845051 | 46 | 0 | BeFree_CTD_human_LHGDN |
| Neoplasm Metastasis | 0.138392034 | 51 | 0 | BeFree_CTD_human_GAD_LHGDN |
| Prostatic Neoplasms | 0.137974753 | 13 | 0 | BeFree_CTD_human_LHGDN |
| Leukemia, Myelocytic, Acute | 0.13549205 | 38 | 0 | BeFree_CTD_human_LHGDN |
| Neuroblastoma | 0.129771907 | 37 | 0 | BeFree_CTD_human |
| Liver neoplasms | 0.128977445 | 17 | 0 | BeFree_CTD_human_LHGDN |
| Bladder Neoplasm | 0.125720142 | 4 | 0 | BeFree_CTD_human_LHGDN |
| Pancreatic Neoplasm | 0.125091382 | 2 | 1 | CTD_human_GAD_LHGDN |
| Non-Small Cell Lung Carcinoma | 0.12434307 | 16 | 0 | BeFree_CTD_human |
| Glioblastoma | 0.123810118 | 6 | 0 | BeFree_CTD_human_LHGDN |
| ovarian neoplasm | 0.123810118 | 6 | 0 | BeFree_CTD_human_LHGDN |
| Hemangiosarcoma | 0.123528744 | 14 | 0 | BeFree_CTD_human |
| Lung Neoplasms | 0.121628651 | 7 | 0 | BeFree_CTD_human |
| Osteosarcoma | 0.121628651 | 7 | 0 | BeFree_CTD_human |
| Stomach Neoplasms | 0.121357209 | 7 | 0 | BeFree_CTD_human |
| Neuroectodermal Tumors | 0.121357209 | 6 | 0 | BeFree_CTD_human |
| Mammary Neoplasms | 0.121116832 | 36 | 0 | BeFree_LHGDN_RGD |
| Lymphoma, Small Noncleaved-Cell | 0.120542884 | 2 | 0 | BeFree_ORPHANET |
| MYELODYSPLASTIC SYNDROME | 0.120271442 | 2 | 0 | BeFree_CTD_human |
| Merkel cell carcinoma | 0.12 | 1 | 0 | CTD_human |
| Hypertrophic Cardiomyopathy | 0.12 | 1 | 0 | CTD_human |
| Neoplastic Cell Transformation | 0.12 | 1 | 0 | CTD_human |
| Cleft Lip | 0.12 | 1 | 0 | CTD_human |
| Cleft Palate | 0.12 | 1 | 0 | CTD_human |
| Fatty Liver | 0.12 | 1 | 0 | CTD_human |
| Polycystic Kidney, Autosomal Dominant | 0.12 | 1 | 0 | CTD_human |
| Left Ventricular Hypertrophy | 0.12 | 1 | 0 | CTD_human |
| Disease Progression | 0.12 | 1 | 0 | CTD_human |
| Chromosome Breakage | 0.12 | 1 | 0 | CTD_human |
| Malignant neoplasm of breast | 0.112888074 | 98 | 0 | BeFree_GAD_MGD |
| Renal Cell Carcinoma | 0.091430353 | 16 | 0 | BeFree_LHGDN_RGD |
| Esophageal Neoplasms | 0.083810118 | 5 | 0 | BeFree_LHGDN_RGD |
| Pancreatic carcinoma | 0.081628651 | 6 | 0 | BeFree_MGD |
| Polycystic Kidney Diseases | 0.080271442 | 2 | 0 | BeFree_RGD |
| Obesity | 0.080271442 | 2 | 0 | BeFree_RGD |
| Diabetes Mellitus, Experimental | 0.08 | 1 | 0 | RGD |
| Cardiomegaly | 0.08 | 1 | 0 | RGD |
| Pulmonary Hypertension | 0.08 | 1 | 0 | RGD |
| Fibroid Tumor | 0.08 | 1 | 0 | RGD |
| Osteoporosis | 0.08 | 1 | 0 | RGD |
| Prolactinoma | 0.08 | 1 | 0 | RGD |
| Shock, Hemorrhagic | 0.08 | 1 | 0 | RGD |
| Coronary Restenosis | 0.08 | 1 | 0 | RGD |
| Prostatic Hyperplasia | 0.08 | 1 | 0 | RGD |
| Lymphoma | 0.071267117 | 217 | 0 | BeFree_GAD_LHGDN |
| B-Cell Lymphomas | 0.04993888 | 113 | 0 | BeFree_GAD_LHGDN |
| Carcinogenesis | 0.034473118 | 127 | 0 | BeFree |
| Diffuse Large B-Cell Lymphoma | 0.029902213 | 85 | 0 | BeFree_GAD |
| Breast Carcinoma | 0.025786978 | 95 | 0 | BeFree |
| Malignant neoplasm of prostate | 0.019587422 | 47 | 3 | BeFree_GAD |
| Multiple Myeloma | 0.018749352 | 50 | 0 | BeFree_LHGDN |
| Adenocarcinoma | 0.018236263 | 22 | 1 | BeFree_LHGDN |
| Malignant neoplasm of lung | 0.014234529 | 37 | 0 | BeFree_GAD |
| melanoma | 0.01387333 | 23 | 0 | BeFree_LHGDN |
| Prostate carcinoma | 0.012486326 | 46 | 3 | BeFree |
| leukemia | 0.011943442 | 44 | 0 | BeFree |
| Colorectal Carcinoma | 0.011596056 | 35 | 4 | BeFree_GAD |
| Squamous cell carcinoma | 0.011530042 | 17 | 0 | BeFree_GAD_LHGDN |
| Colorectal Cancer | 0.011324614 | 34 | 4 | BeFree_GAD |
| Tumor Progression | 0.011129117 | 41 | 0 | BeFree |
| Small cell carcinoma of lung | 0.010857675 | 40 | 0 | BeFree |
| Leukemogenesis | 0.010043349 | 37 | 0 | BeFree |
| Colorectal Neoplasms | 0.00953026 | 8 | 0 | BeFree_LHGDN |
| Malignant neoplasm of stomach | 0.008881637 | 24 | 0 | BeFree_GAD |
| Carcinoma of lung | 0.00868614 | 32 | 0 | BeFree |
| Central neuroblastoma | 0.008414698 | 31 | 0 | BeFree |
| Lymphoma, Non-Hodgkin | 0.007991366 | 13 | 0 | BeFree_GAD |
| Stomach Carcinoma | 0.007871814 | 29 | 0 | BeFree |
| Malignant neoplasm of urinary bladder | 0.007719925 | 13 | 6 | BeFree_GAD |
| Colon Carcinoma | 0.007600372 | 28 | 0 | BeFree |
| Lymphoma, Follicular | 0.007524428 | 20 | 1 | BeFree_GAD |
| Mouth Neoplasms | 0.007458414 | 3 | 0 | GAD_LHGDN |
| Precursor Cell Lymphoblastic Leukemia Lymphoma | 0.006795978 | 16 | 0 | BeFree_LHGDN |
| Anaplasia | 0.006263026 | 4 | 0 | BeFree_LHGDN |
| Chronic Lymphocytic Leukemia | 0.005971721 | 22 | 0 | BeFree |
| Anoxia | 0.0054487 | 2 | 0 | LHGDN |
| Barrett Esophagus | 0.0054487 | 2 | 0 | LHGDN |
| Congenital chromosomal disease | 0.005157396 | 19 | 0 | BeFree |
| Glioma | 0.004895885 | 9 | 0 | BeFree_LHGDN |
| Myeloid Leukemia, Chronic | 0.004885954 | 18 | 0 | BeFree |
| Malignant neoplasm of ovary | 0.004810009 | 10 | 0 | BeFree_GAD |
| Chromosomal translocation | 0.004734064 | 2 | 0 | GAD |
| Retinoblastoma | 0.004624443 | 8 | 0 | BeFree_LHGDN |
| Malignant tumor of colon | 0.004614512 | 17 | 0 | BeFree |
| Acute lymphocytic leukemia | 0.004614512 | 17 | 0 | BeFree |
| Ovarian Carcinoma | 0.00434307 | 16 | 0 | BeFree |
| Plasmacytoma | 0.00434307 | 16 | 0 | BeFree |
| Primary Effusion Lymphoma | 0.00408156 | 6 | 0 | BeFree_LHGDN |
| Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 0.004071628 | 15 | 0 | BeFree |
| Precursor B-cell lymphoblastic leukemia | 0.003800186 | 14 | 0 | BeFree |
| Carcinoma, Transitional Cell | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Hepatitis B | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| T-Cell Lymphoma | 0.003538676 | 4 | 0 | BeFree_LHGDN |
| Immunoblastic Large-Cell Lymphoma | 0.003528744 | 13 | 0 | BeFree |
| Epstein-Barr Virus Infections | 0.003528744 | 13 | 0 | BeFree |
| Plasmablastic lymphoma | 0.003528744 | 13 | 0 | BeFree |
| Rheumatoid Arthritis | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Astrocytoma | 0.003267234 | 2 | 0 | BeFree_LHGDN |
| Papilloma | 0.003267234 | 3 | 0 | BeFree_LHGDN |
| Meningioma | 0.002995792 | 2 | 0 | BeFree_LHGDN |
| Sarcoma, Clear Cell | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Cholangiocarcinoma | 0.002995792 | 2 | 1 | BeFree_LHGDN |
| Secondary malignant neoplasm of lymph node | 0.002985861 | 11 | 0 | BeFree |
| Carcinoma of bladder | 0.002985861 | 11 | 6 | BeFree |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 0.002985861 | 11 | 0 | BeFree |
| Uterine Cervical Neoplasm | 0.00272435 | 1 | 0 | LHGDN |
| Cessation of life | 0.00272435 | 1 | 0 | LHGDN |
| Endometrial Neoplasms | 0.00272435 | 1 | 0 | LHGDN |
| Neoplasms, Germ Cell and Embryonal | 0.00272435 | 1 | 0 | LHGDN |
| Varicose Ulcer | 0.00272435 | 1 | 0 | LHGDN |
| Werner Syndrome | 0.00272435 | 1 | 0 | LHGDN |
| Fibroadenoma | 0.00272435 | 1 | 0 | LHGDN |
| Nijmegen Breakage Syndrome | 0.00272435 | 1 | 0 | LHGDN |
| Infection | 0.00272435 | 1 | 0 | LHGDN |
| Acute Promyelocytic Leukemia | 0.002714419 | 10 | 0 | BeFree |
| Cervix carcinoma | 0.002714419 | 10 | 0 | BeFree |
| Thyroid Diseases | 0.002638474 | 1 | 0 | BeFree_GAD |
| Trisomy | 0.002442977 | 9 | 0 | BeFree |
| Adenocarcinoma of lung (disorder) | 0.002442977 | 9 | 0 | BeFree |
| Alzheimer's Disease | 0.002367032 | 1 | 0 | GAD |
| Chronic Obstructive Airway Disease | 0.002367032 | 1 | 0 | GAD |
| Thyroid Neoplasm | 0.002367032 | 1 | 0 | GAD |
| Acute leukemia | 0.002171535 | 8 | 0 | BeFree |
| Hematologic Neoplasms | 0.002171535 | 8 | 0 | BeFree |
| Sarcoma | 0.002171535 | 8 | 0 | BeFree |
| Hepatocarcinogenesis | 0.002171535 | 8 | 0 | BeFree |
| Nasopharyngeal carcinoma | 0.002171535 | 8 | 0 | BeFree |
| Adenomatous Polyposis Coli | 0.001900093 | 7 | 0 | BeFree |
| Esophageal carcinoma | 0.001900093 | 7 | 0 | BeFree |
| Mucosa-Associated Lymphoid Tissue Lymphoma | 0.001900093 | 7 | 0 | BeFree |
| Medulloblastoma, Childhood | 0.001900093 | 7 | 0 | BeFree |
| Gastric Adenocarcinoma | 0.001900093 | 7 | 0 | BeFree |
| Solid tumour | 0.001900093 | 7 | 0 | BeFree |
| Epithelial ovarian cancer | 0.001900093 | 7 | 0 | BeFree |
| Leukemia, T-Cell | 0.001628651 | 6 | 0 | BeFree |
| Isochromosomes | 0.001628651 | 6 | 0 | BeFree |
| Malignant neoplasm of pancreas | 0.001628651 | 6 | 0 | BeFree |
| Hematopoietic Neoplasms | 0.001628651 | 6 | 0 | BeFree |
| Chromosome 8, trisomy | 0.001628651 | 6 | 0 | BeFree |
| Malignant neoplasm of esophagus | 0.001628651 | 6 | 0 | BeFree |
| Osteosarcoma of bone | 0.001628651 | 6 | 0 | BeFree |
| Squamous cell carcinoma of the head and neck | 0.001628651 | 6 | 0 | BeFree |
| Promyelocytic leukemia | 0.001628651 | 6 | 0 | BeFree |
| Malignant tumor of cervix | 0.001357209 | 5 | 0 | BeFree |
| Lymphoid leukemia | 0.001357209 | 5 | 0 | BeFree |
| Myeloid Leukemia | 0.001357209 | 5 | 0 | BeFree |
| Pheochromocytoma | 0.001357209 | 5 | 0 | BeFree |
| High Grade Lymphoma (neoplasm) | 0.001357209 | 5 | 0 | BeFree |
| Neuroectodermal Tumor, Primitive | 0.001357209 | 5 | 0 | BeFree |
| Squamous cell carcinoma of esophagus | 0.001357209 | 5 | 0 | BeFree |
| Adenocarcinoma Of Esophagus | 0.001357209 | 5 | 0 | BeFree |
| Tumor Initiation | 0.001357209 | 5 | 0 | BeFree |
| Renal carcinoma | 0.001357209 | 5 | 0 | BeFree |
| Vascular lesions | 0.001357209 | 5 | 0 | BeFree |
| Leukemia, B-Cell | 0.001357209 | 5 | 0 | BeFree |
| Adenoma | 0.001085767 | 4 | 0 | BeFree |
| Brain Neoplasms | 0.001085767 | 4 | 0 | BeFree |
| Diabetes | 0.001085767 | 4 | 0 | BeFree |
| Diabetes Mellitus | 0.001085767 | 4 | 0 | BeFree |
| HIV Infections | 0.001085767 | 4 | 0 | BeFree |
| Immunologic Deficiency Syndromes | 0.001085767 | 4 | 0 | BeFree |
| leiomyosarcoma | 0.001085767 | 4 | 0 | BeFree |
| Monosomy | 0.001085767 | 4 | 0 | BeFree |
| Rhabdomyosarcoma | 0.001085767 | 4 | 0 | BeFree |
| Ki-1+ Anaplastic Large Cell Lymphoma | 0.001085767 | 4 | 0 | BeFree |
| Multiple malignancy | 0.001085767 | 4 | 0 | BeFree |
| Secondary malignant neoplasm of liver | 0.001085767 | 4 | 0 | BeFree |
| Thyroid carcinoma | 0.001085767 | 4 | 0 | BeFree |
| Aggressive Non-Hodgkin Lymphoma | 0.001085767 | 4 | 0 | BeFree |
| Mammary Tumorigenesis | 0.001085767 | 4 | 0 | BeFree |
| Non-Neoplastic Disorder | 0.001085767 | 4 | 0 | BeFree |
| Triple Negative Breast Neoplasms | 0.001085767 | 4 | 0 | BeFree |
| Blast Phase | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of thyroid | 0.000814326 | 3 | 0 | BeFree |
| Cholesteatoma | 0.000814326 | 3 | 0 | BeFree |
| Hodgkin Disease | 0.000814326 | 3 | 0 | BeFree |
| Leukemia, Plasma Cell | 0.000814326 | 3 | 0 | BeFree |
| Prolymphocytic Leukemia | 0.000814326 | 3 | 0 | BeFree |
| Adult T-Cell Lymphoma/Leukemia | 0.000814326 | 3 | 0 | BeFree |
| Monoclonal Gammopathy of Undetermined Significance | 0.000814326 | 3 | 0 | BeFree |
| Embryonal Neoplasm | 0.000814326 | 3 | 0 | BeFree |
| Melanocytic nevus | 0.000814326 | 3 | 0 | BeFree |
| Lymphoma, Large-Cell, Follicular | 0.000814326 | 3 | 0 | BeFree |
| Precursor cell lymphoblastic lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Lymphoma, AIDS-Related | 0.000814326 | 3 | 0 | BeFree |
| Liver and Intrahepatic Biliary Tract Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Extraosseous Ewings sarcoma-primitive neuroepithelial tumor | 0.000814326 | 3 | 0 | BeFree |
| Adenocarcinoma of colon | 0.000814326 | 3 | 0 | BeFree |
| African Burkitt's lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of liver | 0.000814326 | 3 | 0 | BeFree |
| Gastric lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site | 0.000814326 | 3 | 0 | BeFree |
| Leukemia, Prolymphocytic, B-Cell | 0.000814326 | 3 | 0 | BeFree |
| Lymphoid neoplasm | 0.000814326 | 3 | 0 | BeFree |
| Ewings sarcoma-primitive neuroectodermal tumor (PNET) | 0.000814326 | 3 | 0 | BeFree |
| Malignant neoplasm of kidney | 0.000814326 | 3 | 0 | BeFree |
| Invasive breast carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Mediastinal (Thymic) Large B-Cell Lymphoma | 0.000814326 | 3 | 0 | BeFree |
| Invasive Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| Radiation-Related Angiosarcoma | 0.000814326 | 3 | 0 | BeFree |
| Cardiomyopathy, Familial Idiopathic | 0.000814326 | 3 | 0 | BeFree |
| Xenograft Model | 0.000814326 | 3 | 1 | BeFree |
| Urothelial Carcinoma | 0.000814326 | 3 | 0 | BeFree |
| T-Cell Prolymphocytic Leukemia | 0.000814326 | 3 | 0 | BeFree |
| Arteriosclerosis | 0.000542884 | 2 | 0 | BeFree |
| Ataxia Telangiectasia | 0.000542884 | 2 | 0 | BeFree |
| Atherosclerosis | 0.000542884 | 2 | 0 | BeFree |
| Carcinoid Tumor | 0.000542884 | 2 | 0 | BeFree |
| Noninfiltrating Intraductal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Chondrosarcoma | 0.000542884 | 2 | 0 | BeFree |
| Choriocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis A | 0.000542884 | 2 | 0 | BeFree |
| Hepatitis, Chronic | 0.000542884 | 2 | 0 | BeFree |
| Leukemia, Lymphocytic, Acute, L1 | 0.000542884 | 2 | 0 | BeFree |
| Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Leukemia, T-Cell, Chronic | 0.000542884 | 2 | 0 | BeFree |
| liposarcoma | 0.000542884 | 2 | 0 | BeFree |
| Liver Cirrhosis | 0.000542884 | 2 | 0 | BeFree |
| Mycosis Fungoides | 0.000542884 | 2 | 0 | BeFree |
| Precancerous Conditions | 0.000542884 | 2 | 0 | BeFree |
| Preleukemia | 0.000542884 | 2 | 0 | BeFree |
| Retroviridae Infections | 0.000542884 | 2 | 0 | BeFree |
| Kaposi Sarcoma | 0.000542884 | 2 | 0 | BeFree |
| Systemic Scleroderma | 0.000542884 | 2 | 0 | BeFree |
| Thrombocythemia, Essential | 0.000542884 | 2 | 0 | BeFree |
| Thymoma | 0.000542884 | 2 | 0 | BeFree |
| Benign Neoplasm | 0.000542884 | 2 | 0 | BeFree |
| Malignant neoplasm of brain | 0.000542884 | 2 | 0 | BeFree |
| Secondary malignant neoplasm of lung | 0.000542884 | 2 | 0 | BeFree |
| Adenocarcinoma, Tubular | 0.000542884 | 2 | 0 | BeFree |
| Medullomyoblastoma | 0.000542884 | 2 | 0 | BeFree |
| Cervical Intraepithelial Neoplasia | 0.000542884 | 2 | 0 | BeFree |
| Inflammatory Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Metastatic melanoma | 0.000542884 | 2 | 0 | BeFree |
| Conventional (Clear Cell) Renal Cell Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Vascular Neoplasms | 0.000542884 | 2 | 0 | BeFree |
| Prostatic Intraepithelial Neoplasias | 0.000542884 | 2 | 0 | BeFree |
| Nodular melanoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant lymphoma - lymphoplasmacytic | 0.000542884 | 2 | 0 | BeFree |
| Giant cell carcinoma of lung | 0.000542884 | 2 | 0 | BeFree |
| Cervical intraepithelial neoplasia grade 1 | 0.000542884 | 2 | 0 | BeFree |
| Early gastric cancer | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of tongue | 0.000542884 | 2 | 0 | BeFree |
| Richter's syndrome | 0.000542884 | 2 | 0 | BeFree |
| High grade B-cell lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Endometrial Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Recurrent tumor | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of skin | 0.000542884 | 2 | 0 | BeFree |
| Squamous cell carcinoma of mouth | 0.000542884 | 2 | 0 | BeFree |
| Carcinoma of larynx | 0.000542884 | 2 | 0 | BeFree |
| invasive cancer | 0.000542884 | 2 | 0 | BeFree |
| extranodal lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Angiosarcoma non-metastatic | 0.000542884 | 2 | 0 | BeFree |
| Metastatic Prostate Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| precancerous lesions | 0.000542884 | 2 | 0 | BeFree |
| Invasive Ductal Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Monoclonal Gammapathies | 0.000542884 | 2 | 0 | BeFree |
| High-Grade Prostatic Intraepithelial Neoplasia | 0.000542884 | 2 | 0 | BeFree |
| Ductal Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Classical Burkitt Lymphoma | 0.000542884 | 2 | 0 | BeFree |
| Pancreatic Ductal Adenocarcinoma | 0.000542884 | 2 | 0 | BeFree |
| Sporadic Breast Carcinoma | 0.000542884 | 2 | 0 | BeFree |
| Malignant Conversion | 0.000542884 | 2 | 0 | BeFree |
| Tumor Angiogenesis | 0.000542884 | 2 | 0 | BeFree |
| Benign Prostatic Hyperplasia | 0.000542884 | 2 | 0 | BeFree |
| Enchondroma | 0.000542884 | 2 | 0 | BeFree |
| Prostate cancer, familial | 0.000542884 | 2 | 0 | BeFree |
| aggressive cancer | 0.000542884 | 2 | 0 | BeFree |
| Congenital Abnormality | 0.000271442 | 1 | 0 | BeFree |
| Acquired Immunodeficiency Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Acromegaly | 0.000271442 | 1 | 0 | BeFree |
| Adrenal Gland Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Breast Diseases | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of endometrium | 0.000271442 | 1 | 0 | BeFree |
| Female Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Mucinous Adenocarcinoma | 0.000271442 | 1 | 0 | BeFree |
| Coronary Arteriosclerosis | 0.000271442 | 1 | 0 | BeFree |
| Coronary heart disease | 0.000271442 | 1 | 1 | BeFree |
| Phyllodes Tumor | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis D Infection | 0.000271442 | 1 | 0 | BeFree |
| Scleroderma | 0.000271442 | 1 | 0 | BeFree |
| Diabetes Mellitus, Insulin-Dependent | 0.000271442 | 1 | 0 | BeFree |
| Epithelial cyst | 0.000271442 | 1 | 0 | BeFree |
| Epilepsy, Temporal Lobe | 0.000271442 | 1 | 0 | BeFree |
| Failure to Thrive | 0.000271442 | 1 | 0 | BeFree |
| Graves Disease | 0.000271442 | 1 | 0 | BeFree |
| Heart Diseases | 0.000271442 | 1 | 0 | BeFree |
| Hepatitis, Alcoholic | 0.000271442 | 1 | 0 | BeFree |
| Intestinal Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Actinic keratosis | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Lymphocytic, Acute, L2 | 0.000271442 | 1 | 0 | BeFree |
| Leukemia, Myeloid, Chronic-Phase | 0.000271442 | 1 | 0 | BeFree |
| Long QT Syndrome | 0.000271442 | 1 | 1 | BeFree |
| Lymphedema | 0.000271442 | 1 | 0 | BeFree |
| Lymphocytosis | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, Undifferentiated | 0.000271442 | 1 | 0 | BeFree |
| Lymphoproliferative Disorders | 0.000271442 | 1 | 0 | BeFree |
| Multiple Personality Disorder | 0.000271442 | 1 | 0 | BeFree |
| Myelodysplasia | 0.000271442 | 1 | 0 | BeFree |
| Myeloproliferative disease | 0.000271442 | 1 | 0 | BeFree |
| Neoplasms, Radiation-Induced | 0.000271442 | 1 | 0 | BeFree |
| Nervous System Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Nevus | 0.000271442 | 1 | 0 | BeFree |
| Parathyroid Neoplasms | 0.000271442 | 1 | 0 | BeFree |
| Pituitary Adenoma | 0.000271442 | 1 | 0 | BeFree |
| Sezary Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Teratoma | 0.000271442 | 1 | 0 | BeFree |
| Xeroderma Pigmentosum | 0.000271442 | 1 | 0 | BeFree |
| Lymphoma, T-Cell, Cutaneous | 0.000271442 | 1 | 0 | BeFree |
| Pleural Effusion, Malignant | 0.000271442 | 1 | 0 | BeFree |
| Polyendocrinopathies, Autoimmune | 0.000271442 | 1 | 0 | BeFree |
| Plasmacytosis | 0.000271442 | 1 | 0 | BeFree |
| Chronic gastritis | 0.000271442 | 1 | 0 | BeFree |
| Monocytosis | 0.000271442 | 1 | 0 | BeFree |
| Adenosis of Breast | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of lung | 0.000271442 | 1 | 0 | BeFree |
| Myocardial Ischemia | 0.000271442 | 1 | 0 | BeFree |
| Cutaneous Melanoma | 0.000271442 | 1 | 0 | BeFree |
| Complete trisomy 18 syndrome | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of mouth | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of gallbladder | 0.000271442 | 1 | 0 | BeFree |
| Subependymal Giant Cell Astrocytoma | 0.000271442 | 1 | 0 | BeFree |
| Liposarcoma, Pleomorphic | 0.000271442 | 1 | 0 | BeFree |
| Germ cell tumor | 0.000271442 | 1 | 0 | BeFree |
| Neuroectodermal Tumor, Melanotic | 0.000271442 | 1 | 0 | BeFree |
| Lichen Planus, Oral | 0.000271442 | 1 | 0 | BeFree |
| Hepatoblastoma | 0.000271442 | 1 | 0 | BeFree |
| Giant Cell Tumor of Bone | 0.000271442 | 1 | 0 | BeFree |
| Alveolar rhabdomyosarcoma | 0.000271442 | 1 | 0 | BeFree |
| Epithelioid hemangioendothelioma | 0.000271442 | 1 | 0 | BeFree |
| Lip and Oral Cavity Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Comedone | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of female breast | 0.000271442 | 1 | 0 | BeFree |
| Gallbladder Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Squamous cell carcinoma of penis | 0.000271442 | 1 | 0 | BeFree |
| Medullary carcinoma of thyroid | 0.000271442 | 1 | 0 | BeFree |
| Papillary thyroid carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Neoplasm, Residual | 0.000271442 | 1 | 0 | BeFree |
| Malignant neoplasm of male breast | 0.000271442 | 1 | 0 | BeFree |
| Multiple tumors | 0.000271442 | 1 | 0 | BeFree |
| Spastic syndrome | 0.000271442 | 1 | 0 | BeFree |
| Cornelia De Lange Syndrome | 0.000271442 | 1 | 0 | BeFree |
| Severe hereditary factor VIII deficiency disease | 0.000271442 | 1 | 0 | BeFree |
| Carcinoma breast stage IV | 0.000271442 | 1 | 0 | BeFree |
| Stage III Prostate Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| metastatic pheochromocytoma | 0.000271442 | 1 | 0 | BeFree |
| stage, non-small cell lung cancer | 0.000271442 | 1 | 0 | BeFree |
| Primary central nervous system lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Malignant lymphoma centroblastic, diffuse | 0.000271442 | 1 | 0 | BeFree |
| Restenosis | 0.000271442 | 1 | 0 | BeFree |
| High-Grade Squamous Intraepithelial Lesions | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma, metastatic | 0.000271442 | 1 | 0 | BeFree |
| Carcinoid tumor no ICD-O subtype | 0.000271442 | 1 | 0 | BeFree |
| Serous cystadenoma, borderline malignancy | 0.000271442 | 1 | 0 | BeFree |
| Inflammatory carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Epithelioid hemangioendothelioma, malignant | 0.000271442 | 1 | 0 | BeFree |
| Thyroid associated opthalmopathies | 0.000271442 | 1 | 0 | BeFree |
| Breast Cancer, Familial | 0.000271442 | 1 | 1 | BeFree |
| Intestinal Cancer | 0.000271442 | 1 | 0 | BeFree |
| Hemimegalencephaly | 0.000271442 | 1 | 0 | BeFree |
| Trisomy 11 | 0.000271442 | 1 | 0 | BeFree |
| Low grade B-cell lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Plasma cell tumor, malignant | 0.000271442 | 1 | 0 | BeFree |
| Ewings sarcoma | 0.000271442 | 1 | 0 | BeFree |
| Toxic Shock Syndrome | 0.000271442 | 1 | 0 | BeFree |
| vascular disease occlusive | 0.000271442 | 1 | 0 | BeFree |
| Primary malignant neoplasm of brain | 0.000271442 | 1 | 0 | BeFree |
| Multiple Sclerosis, Relapsing-Remitting | 0.000271442 | 1 | 0 | BeFree |
| Malignant Pleural Mesothelioma | 0.000271442 | 1 | 0 | BeFree |
| Oestrogen deficiency | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-lymphoblastic lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Leukemia secondary | 0.000271442 | 1 | 0 | BeFree |
| Philadelphia chromosome positive | 0.000271442 | 1 | 0 | BeFree |
| Growth failure | 0.000271442 | 1 | 0 | BeFree |
| Chromosome 17 trisomy | 0.000271442 | 1 | 0 | BeFree |
| Plasma cell dyscrasia | 0.000271442 | 1 | 0 | BeFree |
| Progonoma | 0.000271442 | 1 | 0 | BeFree |
| Atypical teratoid/rhabdoid tumor | 0.000271442 | 1 | 0 | BeFree |
| Chronic leukemia (category) | 0.000271442 | 1 | 0 | BeFree |
| Precursor B-cell lymphoblastic lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Chronic myeloproliferative disorder | 0.000271442 | 1 | 0 | BeFree |
| Partial Trisomy | 0.000271442 | 1 | 0 | BeFree |
| Post-transplant lymphoproliferative disorder, polymorphic | 0.000271442 | 1 | 0 | BeFree |
| Adenoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
| Low Grade Squamous Intraepithelial Neoplasia | 0.000271442 | 1 | 0 | BeFree |
| Papillary Renal Cell Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Skin atheroma | 0.000271442 | 1 | 0 | BeFree |
| Liver regeneration disorder | 0.000271442 | 1 | 0 | BeFree |
| Adenocarcinoma of large intestine | 0.000271442 | 1 | 0 | BeFree |
| AIDS-Related Plasmablastic Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Adult Diffuse Large B-Cell Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Classical Hodgkin's Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Primary Cutaneous Follicle Center Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Hereditary Malignant Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Malignant Mixed Mesodermal (Mullerian) Tumor | 0.000271442 | 1 | 0 | BeFree |
| Mature B-Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Mature B-Cell Non-Hodgkin Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Sporadic Burkitt's lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Well Differentiated Pancreatic Endocrine Tumor | 0.000271442 | 1 | 0 | BeFree |
| Benign melanocytic nevus | 0.000271442 | 1 | 0 | BeFree |
| Desmoplastic | 0.000271442 | 1 | 0 | BeFree |
| Poorly Differentiated Neuroblastoma | 0.000271442 | 1 | 0 | BeFree |
| Smoldering myeloma | 0.000271442 | 1 | 0 | BeFree |
| Glioblastoma Multiforme | 0.000271442 | 1 | 0 | BeFree |
| Atypical Burkitt's lymphoma | 0.000271442 | 1 | 0 | BeFree |
| NUT Midline Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Uterine Corpus Cancer | 0.000271442 | 1 | 0 | BeFree |
| Plasma Cell Neoplasm | 0.000271442 | 1 | 0 | BeFree |
| Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System | 0.000271442 | 1 | 0 | BeFree |
| B-Cell Lymphoma, Unclassifiable, with Features Intermediate between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Plasmablastic Lymphoma of the Oral Mucosa | 0.000271442 | 1 | 0 | BeFree |
| Familial renal cell carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Ocular Adnexal Lymphoma | 0.000271442 | 1 | 0 | BeFree |
| Anaplastic Medulloblastoma | 0.000271442 | 1 | 0 | BeFree |
| Early-Stage Breast Carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Micropapillary carcinoma | 0.000271442 | 1 | 0 | BeFree |
| Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | 0.000271442 | 1 | 0 | BeFree |
| Melanocytic nevus of skin | 0.000271442 | 1 | 0 | BeFree |
| Lymphomas in children | 0.000271442 | 1 | 0 | BeFree |
Retroviral reverse transcription and integration: progress and problems.
10.1146/annurev.cb.08.110192.001423
登陆
忘记密码? 点击找回密码.
